iShares 3 7 Year Treasury Bond ETF vs Johnson & Johnson — how do they compare? iShares 3 7 Year Treasury Bond ETF trades at $116.56, while Johnson & Johnson trades at $250.8 (market cap $598.96B). The key difference: Johnson & Johnson pays a 2.15% dividend while iShares 3 7 Year Treasury Bond ETF pays none, and Johnson & Johnson is trading nearer its 52-week high, iShares 3 7 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| IEI | JNJ | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $120.72 | $267.24 |
52-Week Low | $116.45 | $164.36 |
Market Cap | — | $598.96B |
Volume | — | 6,156,228 |
Enterprise Value | — | $631.90B |
Dividend Yield | — | 2.15% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Johnson & Johnson (JNJ) trades at $250.61, down 0.96% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $2.90 versus $2.84 expected, and revenue growth of 6.6% year-over-year. The stock shows robust profitability with a net income margin of 21.48% and ROE of 26.42%, supported by consistent dividend payments including the recent $1.34 per share declared for H1-2026.
JNJ presents a favorable investment case with analyst consensus price target of $279.33 implying ~11% upside, though rising debt-to-asset ratio to 24.06% in 2025 and volatile cash flow trends pose risks. The healthcare giant's diversified portfolio and raised full-year guidance underpin long-term stability, but investors should monitor execution amid competitive and regulatory pressures.
Trailing returns across standard periods
Latest headlines on both assets
IEI tracks the ICE U.S. Treasury 3-7 Year Bond Index, offering exposure to intermediate-term government debt. It serves as a conservative middle ground in the Treasury yield curve, providing higher yields than short-term bills with less volatility than long-term bonds.
Read more on IEI →Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →